InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: sts66 post# 13423

Wednesday, 09/04/2013 3:30:34 PM

Wednesday, September 04, 2013 3:30:34 PM

Post# of 425931
Isn't it true though that Mochida can't market Epadel in the US because they never pursued approval with the FDA? I would think that "No Epadel = No Generic", right? Also I don't recall reading whether they had ever applied for patents with the USPTO. Wouldn't that mean Vascepa has them trumped no matter what?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News